The AGE2B mission is to build a bridge connecting longevity R&D and the general public, promote new longevity discoveries, support promising developments and make the longevity movement a common, NORMAL part of life. We must increase public interest in research and development, present longevity scientists and companies as the most important individuals and entities, which is needed by everyone.
We’re working with startups and well-established companies in the whole world to identify the most promising products and services, collect all the possible information regarding their effectiveness, and bring them to our seniors.
List of people we expect to market to
User Age | Total Citizens, Million | Our Users, Million |
---|---|---|
70+ | 36 | 1 |
65+ | 17 | 1 |
60+ | 21 | 1 |
55+ | 22 | 2 |
50+ | 20 | 3 |
45+ | 20 | 4 |
40+ | 20 | 4 |
Total | 96 | 16 |
Currently, we’re testing different types of Vendor profiles as Product (Supplements - Glutrasol, Khavinson Peptides) and Service (Doctors/Practices/Clinics) providers
*All the commissions are subject to change without notice, All the previously assigned numbers stay in place for the next 5 years.
Ask your question
We read all your emails and your text. Your question will be responded by our specialists, or one of the doctors we're working with, or our community